David Arida

David Arida has a diverse work experience spanning various industries. David is currently the Chief Operating Officer at Biolinq since April 2023. Before that, they served as the Chief Operating Officer at Cue Health from September 2021 to April 2023. Prior to their role at Biolinq, David worked at Dexcom where they held several positions, including Senior Vice President - Global Manufacturing Operations from September 2020 to September 2021, Vice President of Manufacturing Operations from March 2016 to September 2020, Senior Director of Manufacturing Operations from March 2015 to February 2016, and Director of Operations from October 2011 to March 2015. David also worked at Alere, Inc. as an Associate Director of R&D Services from March 2011 to October 2011, and at Amylin Pharmaceuticals as an Associate Director of Business Operations from February 2008 to March 2011. Prior to that, David worked at PRTM as an Associate in the Life Sciences Practice from July 2007 to February 2008. David began their professional career at Biosite, Inc. as a Senior Engineer/Principle Engineer from October 2002 to July 2005, and at Trex Hawaii as a Project Engineer/Production Manager from September 1999 to September 2002.

David Arida attended Cornell University from 1994 to 1998, where they earned a Bachelor of Science (BS) degree in Chemical Engineering. David then pursued further education at Northwestern University, where they obtained a Master's degree in Engineering Management from 2005 to 2007. During the same period, they also attended Northwestern University's Kellogg School of Management and earned an MBA. In 1998, Arida returned to Cornell University to pursue a Master of Engineering (MEng) degree in Chemical Engineering, which they completed in 1999. In addition to their formal education, Arida has also participated in Continuing Executive Education programs at Stanford University Graduate School of Business and The Wharton School, although specific dates are not provided.